Our data suggest that, despite the low prevalence rate of iron deficiency, middle-aged women are more likely to develop altered iron metabolism because of obesity-related comorbidities and elevated serum hepcidin. This evidence concerns the gene HAMP and obesity due to melanocortin 4 receptor deficiency.